Decreased levels of circulating and tissue miR-107 in human esophageal cancer

Biomarkers

Volumn 18, Issue 4, 2013, Pages 322-330

  Sharma, Priyanka ^a   Saraya, Anoop ^b   Gupta, Prerna ^a   Sharma, Rinu ^a  

^a GURU GOBIND SINGH INDRAPRASTHA UNIVERSITY   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Circulating miRNA; Diagnosis; ESCC; PIM 1; Real time PCR; Sera

Indexed keywords

COMPLEMENTARY DNA; MICRORNA 107; PROTEIN CDC42;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BIOINFORMATICS; DNA SYNTHESIS; DOWN REGULATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE EXPRESSION; GENETIC PARAMETERS; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DOWN-REGULATION; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84878130718     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2013.781677     Document Type: Article

References (68)

1. Arroyo JD, Chevillet JR, Kroh EM, et al. (2011). Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 108:5003-8
2. Ayala de la Peña F, Kanasaki K, Kanasaki M, et al. (2011). Loss of p53 and acquisition of angiogenic microRNA profile are insufficient to facilitate progression of bladder urothelial carcinoma in situ to invasive carcinoma. J Biol Chem 286:20778-87
3. Bateman A, Bennett H. (2009). The granulin gene family: From cancer to dementia. Bioessays 31:1245-54
4. Beier UH, Weise J, Laudien M, et al. (2007). Overexpression of Pim-1 in head and neck squamous cell carcinomas. Int J Oncol 30:1381-7
5. Blanco-Aparicio C, Carnero A. (2012). Pim kinases in cancer: Diagnostic, prognostic and treatment opportunities. Biochem Pharmacol 85: 629-43
6. Boll K, Reiche K, Kasack K, et al. (2012). MiR-130a, miR-203 and miR- 205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma. Oncogene 32:277-85
7. Boyle EI, Weng S, Gollub J, et al. (2004). GO:TermFinder - open source software for accessing Gene Ontology information and finding significantly enriched Gene Ontology terms associated with a list of genes. Bioinformatics 20:3710-15 (Pubitemid 40136825)
8. Calin GA, Croce CM. (2006). MicroRNA signatures in human cancers. Nat Rev Cancer 6:857-66 (Pubitemid 44629897)
9. Calin GA, Dumitru CD, Shimizu M, et al. (2002). Frequent deletions and downregulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99:15524-9 (Pubitemid 35403967)
10. Calin GA, Liu CG, Sevignani C, et al. (2004). MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA 101:11755-60 (Pubitemid 39095368)
11. Chen J, Kobayashi M, Darmanin S, et al. (2009). Hypoxia-931 mediated up-regulation of Pim-1 contributes to solid tumor formation. Am J Pathol 175:400-11
12. Chen PS, Su J, Cha ST, et al. (2011). miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans. J Clin Invest 121:3442-55
13. Chen X, Ba Y, Ma L, et al. (2008). Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18:997-1006
14. Cheng AM, Byrom MW, Shelton J, Ford LP. (2005). Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 33:1290-7 (Pubitemid 41439922)
15. Cheung ST, Wong S, Leung KL, et al. (2004). Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma. Clin Cancer Res 10:7629-36 (Pubitemid 39557526)
16. Chiang WF, Yen C, Lin CN, et al. (2006). Up-regulation of a serinethreonine kinase proto-oncogene Pim-1 in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 35:740-5 (Pubitemid 43906168)
17. Cohen AM, Grinblat B, Bessler H, et al. (2004). Increased expression of the hPim-2 gene in human chronic lymphocytic leukemia and non- Hodgkin lymphoma. Leuk Lymphoma 45:951-5 (Pubitemid 38444671)
18. Davidson B, Alejandro E, Florenes VA, et al. (2004). Granulin-epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma. Cancer 100:2139-47 (Pubitemid 38580332)
19. Donald CD, Laddu A, Chandham P, et al. (2001). Expression of progranulin and the epithelin/granulin precursor acrogranin correlates with neoplastic state in renal epithelium. Anticancer Res 21: 3739-42 (Pubitemid 34229235)
20. Feng JG, Liu Q, Qin X, et al. (2012a). Clinicopathological pattern and Annexin A2 and Cdc42 status in patients presenting with differentiation and lymphnode metastasis of esophageal squamous cell carcinomas. Mol Biol Rep 39:1267-74
21. Feng L, Xie Y, Zhang H, Wu Y. (2012b). miR-107 targets cyclindependent kinase 6 expression, induces cell cycle G1 arrest and inhibits invasion in gastric cancer cells. Med Oncol 29:856-63
22. Ferlay J, Shin H, Bray F, et al. (2010). GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer
23. Fritz G, Brachetti C, Bahlmann F, et al. (2002). Rho GTPases in human breast tumours: Expression and mutation analyses and correlation with clinical parameters. Br J Cancer 87:635-44
24. Fritz G, Just I, Kaina B. (1999). Rho GTPases are over-expressed in human tumors. Int J Cancer 81:682-7 (Pubitemid 29214373)
25. Garzon R, Pichiorri F, Palumbo T, et al. (2007). MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene 26:4148-57 (Pubitemid 46920170)
26. Gomez Del Pulgar T, Valde's-Mora F, Bandres E, et al. (2008). Cdc42 is highly expressed in colorectal adenocarcinoma and downregulates ID4 through an epigenetic mechanism. Int J Oncol 33:185-93
27. Gu JJ, Wang Z, Reeves R, Magnuson NS. (2009). PIM1 phosphorylates and negatively regulates ASK1-mediated apoptosis. Oncogene 28: 4261-71
28. Guo S, Mao X, Chen J, et al. (2010). Overexpression of Pim-1 in bladder cancer. J Exp Clin Cancer Res 29:161
29. Guo Y, Chen Z, Zhang L, et al. (2008). Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res 68:26-33 (Pubitemid 351380102)
30. Hamano R, Miyata H, Yamasaki M, et al. (2011). Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway. Clin Cancer Res 17: 3029-38
31. Hayashita Y, Osada H, Tatematsu Y, et al. (2005). A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65:9628-32 (Pubitemid 41541436)
32. Hennessy EJ, Sheedy F, Santamaria D, et al. (2011). Toll-like receptor-4 (TLR4) down-regulates microRNA-107, increasing macrophage adhesion via cyclin-dependent kinase 6. J Biol Chem 286:25531-9
33. Hummel R, Watson D, Smith C, et al. (2011). Mir-148a improves response to chemotherapy in sensitive and resistant oesophageal adenocarcinoma and squamous cell carcinoma cells. J Gastrointest Surg 15:429-38
34. Hutva'gner G, Zamore PD. (2002). A microRNA in a multiple-turnover RNAi enzyme complex. Science 297:2056-60
35. Jones MB, Michener C, Blanchette JO, et al. (2003). The granulinepithelin precursor/PC-cellderived growth factor is a growth factor for epithelial ovarian cancer. Clin Cancer Res 9:44-51 (Pubitemid 36109714)
36. Kamai T, Yamnishi T, Shirataki H, et al. (2004). Overexpression of RhoA, Rac1, and Cdc42 GTPases is associated with progression in testicular cancer. Clin Cancer Res 10:4799-805 (Pubitemid 38955533)
37. Kroh EM, Parkin RK, Mitchell PS, Tewari M. (2010). Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 50: 298-301
38. Ladeiro Y, Couchy G, Balabaud C, et al. (2008). MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/ tumor suppressor gene mutations. Hepatology 47:1955-63 (Pubitemid 351952843)
39. Lee KH, Lotterman C, Karikari C, et al. (2009). Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer. Pancreatology 9:293-301
40. Li S, Xi Y, Zhang H, et al. (2010). A pivotal role for Pim-1 kinase in esophageal squamous cell carcinoma involving cell apoptosis induced by reducing Akt phosphorylation. Oncol Rep 24:997-1004
41. Li X, Lin R, Li J. (2011). Epigenetic silencing of microRNA-375 regulates PDK1 expression in esophageal cancer. Dig Dis Sci 56: 2849-56
42. Liu HT, Wang N, Wang X, Li SL. (2010). Overexpression of Pim-1 is associated with poor prognosis in patients with esophageal squamous cell carcinoma. J Surg Oncol 102:683-8
43. Liu Q, Lv. G, Qin X, et al. (2012). Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma. Mol Biol Rep 39: 1239-46
44. Liu X, Chen Z, Yu J, et al. (2009a). MicroRNA profiling and head and neck cancer. Comp Funct Genomics Article ID: 837514
45. Liu Y,Wang Y, Zhang Y,Wang E. (2009b). Abnormal expression of p120- catenin, E-cadherin, and small GTPases is significantly associated with malignant phenotype of human lung cancer. Lung Cancer 63:375-82
46. Liu Z, Feng J, Tuersun A, et al. (2011). Proteomic identification of differentially-expressed proteins in esophageal cancer in three ethnic groups in Xinjiang. Mol Biol Rep 38:3261-9
47. Megraw M, Sethupathy P, Corda B, Hatzigeorgiou AG. (2007). miRGen: A database for the study of animal microRNA genomic organization and function. Nucleic Acids Res 35:D149-55 (Pubitemid 46056188)
48. Mitchell PS, Parkin RK, Kroh EM, et al. (2008). Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105:10513-18
49. Moncini S, Salvi A, Zuccotti P, et al. (2011). The role of miR-103 and miR-107 in regulation of CDK5R1 expression and in cellular migration. PLoS One 6:e20038
50. Nawijn MC, Alendar A, Berns A. (2011). For better or for worse: The role of Pim oncogenes in tumorigenesis. Nat Rev Cancer 11:23-34
51. Ogawa R, Ishiguro H, Kuwabara Y, et al. (2009). Expression profiling of micro-RNAs in human esophageal squamous cell carcinoma using RT-PCR. Med Mol Morphol 42:102-9
52. Polster BJ, Westaway S, Nguyen TM, et al. (2010). Discordant expression of miR-103/7 and pantothenate kinase host genes in mouse. Mol Genet Metab 101:292-5
53. Reiser-Erkan C, Erkan M, Pan Z, et al. (2008). Hypoxia-inducible protooncogene Pim-1 is a prognostic marker in pancreatic ductal adenocarcinoma. Cancer Biol Ther 7:1352-9
54. Roldo C, Missiaglia E, Hagan JP, et al. (2006). MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 24:4677-84 (Pubitemid 46630931)
55. Saxena S, Jo'nsson ZO, Dutta A. (2003). Small RNAs with imperfect match to endogenous mRNA repress translation. Implications for offtarget activity of small inhibitory RNA in mammalian cells. J Biol Chem 278:44312-19 (Pubitemid 37377177)
56. Schepeler T, Reinert J, Ostenfeld MS, et al. (2008). Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res 68: 6416-24
57. Takahashi Y, Forrest A, Maeno E, et al. (2009). MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines. PLoS One 4:e6677
58. The UniProt Consortium. (2012). Reorganizing the protein space at the Universal Protein Resource (UniProt). Nucleic Acids Res 40:D71-5. Available from: Http://www.uniprot.org/uniprot/P11309 [last accessed 10 Oct 2012].
59. Tian Y, Luo A, Cai Y, et al. (2010). MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines. J Biol Chem 285:7986-94
60. Tucci MG, Lucarini G, Brancorsini D, et al. (2007). Involvement of Ecadherin, beta-catenin, Cdc42 and CXCR4 in the progression and prognosis of cutaneous melanoma. Br J Dermatol 157:1212-16 (Pubitemid 350115706)
61. Wang J, Kim J, Roh M, et al. (2010a). Pim1 kinase synergizes with c- MYC to induce advanced prostate carcinoma. Oncogene 29:2477-87
62. Wang WX, Rajeev B, Stromberg AJ, et al. (2008). The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci 28:1213-23
63. Wang WX, Wilfred B, Madathil SK, et al. (2010b). MiR-107 Regulates granulin/progranulin with implications for traumatic brain injury and neurodegenerative disease. Am J Pathol 177:334-45
64. Warnecke-Eberz U, Bollschweiler E, Drebber U, et al. (2009). Prognostic impact of protein overexpression of the proto-oncogene PIM-1 in gastric cancer. Anticancer Res 29:4451-5
65. Wong TS, Liu X, Wong BY, et al. (2008). Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res 14:2588-92
66. Wu Q, Wang C, Lu Z, et al. (2012). Analysis of serum genome-wide microRNAs for breast cancer detection. Clin Chim Acta 413:1058-65
67. Yamakuchi M, Lotterman C, Bao C, et al. (2010). P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis. Proc Natl Acad Sci USA 107:6334-9
68. Zhang F, Beharry Z, Harris TE, et al. (2009). PIM1 protein kinase regulates PRAS40 phosphorylation and mTOR activity in FDCP1 cells. Cancer Biol Ther 8:846-53.